跳至主要内容
临床试验/NL-OMON49003
NL-OMON49003已完成不适用

A randomised controlled trial comparing FMT (fecal microbiota transplantation) after budesonide or placebo in patients with active ulcerative colitis: ;Acronym: the FECBUD trial - FMT for ulcerative colitis after initiation of budesonide

eids Universitair Medisch Centrum0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • patients > 18 years old (n<=24) with mild or moderate activity of ulcerative
  • colitis despite previous maintenance therapy (mesalazine, or thiopurine, or
  • anti-TNF, or vedolizumab) with a MAYO endoscopic subscore of I or II and with
  • written informed consent.

排除标准

  • amongst others: pregnancy, need for (continuous) antibiotic treatment, previous
  • prednisolon or budenofalk resistant inflammation

研究者

相似试验